ATLANTA, Feb. 16, 2017 -- Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has entered into an agreement with MUCOM, L.L.C. to broker the sale or license of its patented male urinary incontinence device MUI Comfort™.
MUI Comfort™ is an integrated external collection system that meets the needs of a growing demographic that is coping with the consequences of stress, urge, and overflow incontinence. This innovative technology is differentiated from competing products by providing a complete solution that addresses both functional and psychological aspects associated with male urinary incontinence. MUI Comfort™ has several elements that are central to its patented design including:
- A lightweight collection bag with an integrated drainage neck and secured opening.
- A soft inner liner to protect the skin from perspiration and potential allergenic reaction.
- An enlarged opening with an adjustable closure mechanism that is part of three key elements that prevent accidental leaks, protect the skin, and provide secure fixation.
- A wicking component that draws urine into a superabsorbent-deodorizing polymer and will bond with any liquid to minimize odor, prevent sloshing and leakage.
- Watch the video
“We are excited to be working with the MUCOM team and representing such innovative technology that can provide millions of effected men with a superior management option for their stress, urge, and overflow incontinence,” commented Paul Gianneschi, Managing Principal at Hatch Medical L.L.C.
Donna Lou DuPree McCormack, RN, BSN, President of MUCOM, LLC commented, “We are excited to offer this innovative technology to countless men who are subjected to the embarrassment and social isolation of urinary incontinence, who have been underserved by disappointing products. Our patented technology has the potential to enhance the wellness and quality of life for untold millions of males as they eliminate the use of diapers and pads. We are delighted to be working with Hatch Medical to bring this new technology to the market.”
Founded in 2000, Hatch Medical is an incubator and broker of medical device technologies, assisting clients with development, licensing, distribution and asset sales. For information on this, or other Hatch Medical, L.L.C. products and services, email the company at [email protected]. This release and additional news about Hatch Medical can be obtained by visiting the company’s web site -- http://www.hatchmedical.com.
Contact Paul Gianneschi, Managing Principal, 770-476-9940, Steve Hvozda, Principal 949-388-9335, or Gary Robinson 215-353-0362


Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 



